Archive | ELN RSS feed for this section

Managing IP today

2 Apr

Blue and red fibre optical cables

Drivers such as the expiration of pharmaceutical patents, legal and regulatory reforms, and social and cost pressures have increased the value of intellectual property (IP). At the same time, new collaborative ways of working and the externalization of certain workflows and processes have created IP opportunities and threats; while a shift in emphasis to so-called ‘soft’ IP rights or non-patent IP has changed the way in which companies understand and value IP.

Continue Reading »

Data management technology in the lab of the future

29 Jan


Research and development (R&D) is changing. And with concepts such as the ‘lab of the future’ and the ‘paperless lab’ becoming more common, it’s important to understand what these terms really mean in practice. The lab of the future is not just about replacing notebooks with electronic versions. Today’s concept of the ‘paperless lab’ goes well beyond that.

Continue Reading »

Hot topics in R&D data management for 2015

19 Jan


The New Year is already in full swing and as we move wholeheartedly into 2015, a look into the crystal ball shows exciting developments for research and development (R&D) across all domains. Will this be the year that scientists cure a major disease or make significant treatment advances? Or perhaps a new biofuel will reduce the world’s reliance on fossil fuels and change the way we live.

Continue Reading »

Onwards and upwards: IT and automation in the lab

2 Dec


The move towards automation has been a key trend in the pharma and biotech sectors. We’ve seen the robotic handling and processing of samples move from high-throughput screening domains onto the discovery bench. Almost every lab now has a liquid handling or clone/cell-picking robot, and high-content single-cell screening instruments are replacing fluorescence-activated cell sorters. Scientists want to see seamless flows of data from lab instruments into processing, analysis and knowledge platforms. Guest blogger Agnes Huot, former Director of R&D IT at Biogen Idec, explains.

Continue Reading »

X marks the spot: optimizing cell culture development

25 Nov

treasure map image

Data. It’s everywhere and every day, more and more is being generated by scientists in research and development (R&D) cell culture labs. This data is a highly valuable asset so long as it can be accessed and linked together efficiently for analysis. Data which isn’t searchable or housed with appropriate context ultimately slows down discovery. It’s like having a treasure map you’re unable to read: potential for great things but not a lot of use. So how can we unlock the value of data and make real breakthroughs in R&D?

Continue Reading »